IBDEI1GW ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26316,1,4,0)
 ;;=4^295.90
 ;;^UTILITY(U,$J,358.3,26316,2)
 ;;=^108287
 ;;^UTILITY(U,$J,358.3,26317,0)
 ;;=304.10^^154^1604^83
 ;;^UTILITY(U,$J,358.3,26317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26317,1,3,0)
 ;;=3^Sedative, Hypnotic, Anxio Depend
 ;;^UTILITY(U,$J,358.3,26317,1,4,0)
 ;;=4^304.10
 ;;^UTILITY(U,$J,358.3,26317,2)
 ;;=^331931
 ;;^UTILITY(U,$J,358.3,26318,0)
 ;;=305.40^^154^1604^82
 ;;^UTILITY(U,$J,358.3,26318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26318,1,3,0)
 ;;=3^Sedative, Hypnotic, Anxio Abuse
 ;;^UTILITY(U,$J,358.3,26318,1,4,0)
 ;;=4^305.40
 ;;^UTILITY(U,$J,358.3,26318,2)
 ;;=^331935
 ;;^UTILITY(U,$J,358.3,26319,0)
 ;;=780.99^^154^1604^58
 ;;^UTILITY(U,$J,358.3,26319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26319,1,3,0)
 ;;=3^Other General Symptoms
 ;;^UTILITY(U,$J,358.3,26319,1,4,0)
 ;;=4^780.99
 ;;^UTILITY(U,$J,358.3,26319,2)
 ;;=^328568
 ;;^UTILITY(U,$J,358.3,26320,0)
 ;;=780.79^^154^1604^36
 ;;^UTILITY(U,$J,358.3,26320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26320,1,3,0)
 ;;=3^General Weakness
 ;;^UTILITY(U,$J,358.3,26320,1,4,0)
 ;;=4^780.79
 ;;^UTILITY(U,$J,358.3,26320,2)
 ;;=^73344
 ;;^UTILITY(U,$J,358.3,26321,0)
 ;;=369.4^^154^1604^46
 ;;^UTILITY(U,$J,358.3,26321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26321,1,3,0)
 ;;=3^Legal Blindness (USA Definition)
 ;;^UTILITY(U,$J,358.3,26321,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,26321,2)
 ;;=^268887
 ;;^UTILITY(U,$J,358.3,26322,0)
 ;;=413.9^^154^1604^5
 ;;^UTILITY(U,$J,358.3,26322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26322,1,3,0)
 ;;=3^Angina Pectoris NEC/NOS
 ;;^UTILITY(U,$J,358.3,26322,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,26322,2)
 ;;=^87258
 ;;^UTILITY(U,$J,358.3,26323,0)
 ;;=300.00^^154^1604^6
 ;;^UTILITY(U,$J,358.3,26323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26323,1,3,0)
 ;;=3^Anxiety
 ;;^UTILITY(U,$J,358.3,26323,1,4,0)
 ;;=4^300.00
 ;;^UTILITY(U,$J,358.3,26323,2)
 ;;=^9200
 ;;^UTILITY(U,$J,358.3,26324,0)
 ;;=716.90^^154^1604^8
 ;;^UTILITY(U,$J,358.3,26324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26324,1,3,0)
 ;;=3^Arthropathy NOS
 ;;^UTILITY(U,$J,358.3,26324,1,4,0)
 ;;=4^716.90
 ;;^UTILITY(U,$J,358.3,26324,2)
 ;;=^66343
 ;;^UTILITY(U,$J,358.3,26325,0)
 ;;=314.00^^154^1604^9
 ;;^UTILITY(U,$J,358.3,26325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26325,1,3,0)
 ;;=3^Attention Defic Nonhyperactive
 ;;^UTILITY(U,$J,358.3,26325,1,4,0)
 ;;=4^314.00
 ;;^UTILITY(U,$J,358.3,26325,2)
 ;;=^268351
 ;;^UTILITY(U,$J,358.3,26326,0)
 ;;=496.^^154^1604^17
 ;;^UTILITY(U,$J,358.3,26326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26326,1,3,0)
 ;;=3^Chr Airway Obstruction NEC
 ;;^UTILITY(U,$J,358.3,26326,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,26326,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,26327,0)
 ;;=585.3^^154^1604^21
 ;;^UTILITY(U,$J,358.3,26327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26327,1,3,0)
 ;;=3^Chr Kidney Disease,Stage III
 ;;^UTILITY(U,$J,358.3,26327,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,26327,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,26328,0)
 ;;=585.4^^154^1604^22
 ;;^UTILITY(U,$J,358.3,26328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26328,1,3,0)
 ;;=3^Chr Kidney Disease,Stage IV
 ;;^UTILITY(U,$J,358.3,26328,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,26328,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,26329,0)
 ;;=585.1^^154^1604^19
 ;;^UTILITY(U,$J,358.3,26329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26329,1,3,0)
 ;;=3^Chr Kidney Disease,Stage I
 ;;^UTILITY(U,$J,358.3,26329,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,26329,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,26330,0)
 ;;=585.2^^154^1604^20
